查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1722528

2025 年至 2033 年黃斑部病變治療市場報告（按類型、疾病階段、給藥途徑、最終用戶和地區分類）

Macular Degeneration Treatment Market Report by Type, Stage of Disease, Route of Administration, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2024年全球黃斑部病變治療市場規模達99億美元。展望未來， IMARC Group預計到2033年市場規模將達到158億美元，2025-2033年期間的成長率（CAGR）為5.28%。市場的主要驅動力是人群中老年性黃斑部病變和肥胖症的發病率不斷上升、久坐不動的生活方式日益盛行、智慧設備的快速使用以及醫療保健基礎設施的顯著改善，尤其是在發展中經濟體。

黃斑部病變是一種影響眼睛的神經退化性眼部疾病，會導致視野中心視力模糊或喪失。其特徵是視野中存在盲點、視覺扭曲以及在低光源條件下無法看清東西。一些常用的黃斑部病變治療技術包括抗血管新生藥物、光動力雷射療法、隱形眼鏡和過渡鏡片。雷射治療包括將專門的隱形眼鏡插入眼睛的患處，並用雷射將患處和血管封住。抗血管新生藥物用於防止血管阻塞和滲漏。及時治療黃斑部病變有助於增強視力並最大限度地降低慢性失明的風險。

黃斑部病變治療市場趨勢：

人群中年齡相關性黃斑部病變和肥胖症發病率的增加是推動市場成長的關鍵因素之一。飲食習慣的改變和久坐不動的生活方式的日益盛行導致了黃斑部病變的發展。此外，智慧型手機、筆記型電腦和電視的使用率不斷增加，導致螢幕使用時間延長和過長，這也影響了這種疾病的發生。此外，涉及將腺相關病毒（AAV）注射到體內以防止異常血管發育的視網膜基因療法的發展正在推動市場成長。與此相符的是，醫療保健基礎設施的顯著改善對市場成長產生了積極影響。其他因素，包括為開發創新有效藥物而進行的廣泛研究和開發 (R&D) 活動，以及政府為促進公共健康而實施的各種舉措，預計將推動市場成長。

本報告回答的關鍵問題

  • 2024 年全球黃斑部病變治療市場規模？ 2025 年至 2033 年期間全球黃斑部病變治療市場的預期成長率為何？
  • 推動全球黃斑部病變治療市場發展的關鍵因素有哪些？
  • COVID-19 對全球黃斑部病變治療市場有何影響？
  • 根據類型，全球黃斑部病變治療市場是如何分佈的？
  • 根據疾病的階段，全球黃斑部病變治療市場是如何分佈的？
  • 根據給藥途徑，全球黃斑部病變治療市場如何分佈？
  • 根據最終用戶，全球黃斑部病變治療市場的分佈如何？
  • 全球黃斑部病變治療市場的主要區域有哪些？
  • 全球黃斑部病變治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球黃斑部病變治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 乾性老年黃斑部病變
  • 濕性老年性黃斑部病變

第7章：市場區隔：依疾病階段

  • 早期
  • 中級階段
  • 後期

第8章：市場區隔：依行政途徑

  • 靜脈途徑
  • 玻璃體內途徑

第9章：市場區隔：依最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Aerie Pharmaceuticals Inc.
    • Bausch Health Companies Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd
    • Iveric Bio Inc.
    • Novartis AG
    • Panoptica
    • Pfizer Inc.
    • Phio Pharmaceuticals
    • Regeneron Pharmaceuticals Inc.
    • Regenxbio Inc.
    • Santen Pharmaceutical Co. Ltd.
Product Code: SR112025A5118

The global macular degeneration treatment market size reached USD 9.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.28% during 2025-2033. The market is majorly driven by the increasing incidences of age-related macular degeneration and obesity among the masses, growing prevalence of sedentary lifestyles, rapid utilization of smart devices, and significant improvements in the healthcare infrastructure, particularly in developing economies.

Macular degeneration is a neurodegenerative ocular disorder that affects the eyes and causes blurred or loss of vision in the center of the visual field. It is characterized by blind spots in the field of vision, visual distortions and inability to see in low light conditions. Some of the commonly used therapeutic techniques for macular degeneration includes anti-angiogenic drugs, photodynamic laser therapies, contact lenses and transitional lenses. Laser therapy involves the insertion of specialized contact lenses into the affected are of the eye, which are sealed by lasers along with the blood vessels. Anti-angiogenic drugs are used for preventing blockages and leakages in the blood vessels. Timely treatment of macular degeneration treatment can aid in enhancing vision and minimizing the risks of developing chronic blindness.

Macular Degeneration Treatment Market Trends:

The increasing incidences of age-related macular degeneration and obesity among the masses is one of the key factors driving the market growth. The changing dietary patterns and the rising adoption of sedentary lifestyles is leading to the development of macular degeneration. Additionally, the increasing utilization of smartphones, laptops and television, which is leading to prolonged and excessive screen time is also impacting the occurrence of the disorder. Moreover, the development of retinal gene therapies that involves the injection of adeno-associated virus (AAV) into the body for preventing the development of abnormal blood vessels is providing a thrust to the market growth. In line with this, significant improvements in the healthcare infrastructure is positively impacting the market growth. Other factors, including extensive research and development (R&D) activities for the development of innovative and effective drugs, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Type:

  • Dry Age-related Macular Degeneration
  • Wet Age-related Macular Degeneration

Breakup by Stage of Disease:

  • Early Stage
  • Intermediate Stage
  • Late Stage

Breakup by Route of Administration:

  • Intravenous Route
  • Intravitreal Route

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Center
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.

Key Questions Answered in This Report

  • 1.What was the size of the global macular degeneration treatment market in 2024?
  • 2.What is the expected growth rate of the global macular degeneration treatment market during 2025-2033?
  • 3.What are the key factors driving the global macular degeneration treatment market?
  • 4.What has been the impact of COVID-19 on the global macular degeneration treatment market?
  • 5.What is the breakup of the global macular degeneration treatment market based on the type?
  • 6.What is the breakup of the global macular degeneration treatment market based on the stage of disease?
  • 7.What is the breakup of the global macular degeneration treatment market based on the route of administration?
  • 8.What is the breakup of the global macular degeneration treatment market based on the end user?
  • 9.What are the key regions in the global macular degeneration treatment market?
  • 10.Who are the key players/companies in the global macular degeneration treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Macular Degeneration Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Dry Age-related Macular Degeneration
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Wet Age-related Macular Degeneration
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Stage of Disease

  • 7.1 Early Stage
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intermediate Stage
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Late Stage
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous Route
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intravitreal Route
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Center
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Aerie Pharmaceuticals Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Iveric Bio Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Panoptica
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pfizer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phio Pharmaceuticals
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Regeneron Pharmaceuticals Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Regenxbio Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Santen Pharmaceutical Co. Ltd.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2024
  • Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2024
  • Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
  • Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
  • Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million USD), 2025-2033
  • Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
  • Table 8: Global: Macular Degeneration Treatment Market: Key Players